CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

HEALTHCARE SUPPLIER NEWS

Merck inks $394M takeover of oncolytic virus play Viralytics

Published: Wed, 21 Feb 2018 10:47:21 +0000
Merck is set to pay $394 million to acquire Viralytics. The takeover will give Merck control of an oncolytic immunotherapy that Viralytics is testing in combination with Keytruda in early-phase trials.

Ionis farms out antisense drug to AstraZeneca in deal worth up to $330M

Published: Tue, 20 Feb 2018 15:25:40 +0000
Ionis Pharmaceuticals has licensed an antisense drug for the treatment of kidney disease to AstraZeneca, picking up a $30 million payment in the process.

Aimmune aces peanut allergy phase 3, teeing up FDA filing

Published: Tue, 20 Feb 2018 13:25:58 +0000
Aimmune has presented strong data from a phase 3 trial of its peanut allergy treatment AR101. The Brisbane, California-based biotech plans to file for FDA approval by the end of 2018 to give patients a way to protect themselves against accidental exposure to peanut protein.
Displaying results 10-12 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top